First, the mRNA level of RHBDF2 was investigated in human cancers with the TIMER database, and we found that RHBDF2 mRNA expression was upregulated in most human tumors, including HCC (LIHC; Fig. 1A). Here, RHBDF2 is linked to hepatocellular carcinoma.